FindTrial
Sign In

Validation of peripheral limb pulasation therapy in patients with heart failure.

Validation of External Counterpulsation (ECP) therapy in patients of stable congestive cardiac failure.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015654
Enrollment
26
Registered
2018-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I259- Chronic ischemic heart disease, unspecified

Interventions

Intervention1: EECP DEVICE: EECP is an accepted therapeutic option in the treatment of angina for the past two decades with a record of safety and,is supported with clinical evidence in the form of pu

Sponsors

Defence Research and Development Organisation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age 18-65 years . 2. Patients of Congestive cardiac failure stage B and C according to American college of cardiology and American heart association guidelines. B- Patients having structural changes â?? Left ventricular hypertrophy , Reduced Ejection fraction but no symptoms. C- Patients with structural changes and symptoms

Exclusion criteria

Exclusion criteria: 1. Patients having acute cardiac ischemia. 2. Patients with grade 4 CCF.. 3. Patients having arrhythmias. 4. Patients having any hemodynamic instability due to any cause

Design outcomes

Primary

MeasureTime frame
1. Improvement in quality of life score 2. Improvement in Echo parameters and Ejection fraction. 3. Improvement in ABPI Timepoint: 1. 35th day 2. 35th day 3. 35th day—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactAshwin Kulkarni

Ramaiah Medical College

drashwinkulkarni@yahoo.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026